Literature DB >> 14576179

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity.

Terry P Combs1, Utpal B Pajvani, Anders H Berg, Ying Lin, Linda A Jelicks, Mathieu Laplante, Andrea R Nawrocki, Michael W Rajala, Albert F Parlow, Laurelle Cheeseboro, Yang-Yang Ding, Robert G Russell, Dirk Lindemann, Adam Hartley, Glynn R C Baker, Silvana Obici, Yves Deshaies, Marian Ludgate, Luciano Rossetti, Philipp E Scherer.   

Abstract

Adiponectin is a plasma protein expressed exclusively in adipose tissue. Adiponectin levels are linked to insulin sensitivity, but a direct effect of chronically elevated adiponectin on improved insulin sensitivity has not yet been demonstrated. We identified a dominant mutation in the collagenous domain of adiponectin that elevated circulating adiponectin values in mice by 3-fold. Adiponectinemia raised lipid clearance and lipoprotein lipase activity, and suppressed insulin-mediated endogenous glucose production. The induction of adiponectin during puberty and the sexual dimorphism in adult adiponectin values were preserved in these transgenic animals. As a result of elevated adiponectin, serum PRL values and brown adipose mass both increased. The effects on carbohydrate and lipid metabolism were associated with elevated phosphorylation of 5'-AMP-activated protein kinase in liver and elevated expression of peroxisomal proliferator-activated receptor gamma2, caveolin-1, and mitochondrial markers in white adipose tissue. These studies strongly suggest that increasing endogenous adiponectin levels has direct effects on insulin sensitivity and may induce similar physiological responses as prolonged treatment with peroxisomal proliferator-activated receptor gamma agonists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576179     DOI: 10.1210/en.2003-1068

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  175 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

2.  Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes.

Authors:  Shira Landskroner-Eiger; Jiyoung Park; Davelene Israel; Jeffrey W Pollard; Philipp E Scherer
Journal:  Dev Biol       Date:  2010-06-19       Impact factor: 3.582

3.  Gender differences in adiponectin modulation of cardiac remodeling in mice deficient in endothelial nitric oxide synthase.

Authors:  Jorge L Durand; Andrea R Nawrocki; Philipp E Scherer; Linda A Jelicks
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

4.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

5.  Systematic detection of internal symmetry in proteins using CE-Symm.

Authors:  Douglas Myers-Turnbull; Spencer E Bliven; Peter W Rose; Zaid K Aziz; Philippe Youkharibache; Philip E Bourne; Andreas Prlić
Journal:  J Mol Biol       Date:  2014-03-26       Impact factor: 5.469

Review 6.  Adipocyte-derived hormones, cytokines, and mediators.

Authors:  Cristina M Rondinone
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 7.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Inhibition of ERK1/2 pathway suppresses adiponectin secretion via accelerating protein degradation by Ubiquitin-proteasome system: relevance to obesity-related adiponectin decline.

Authors:  Dongfang Gu; Zhigang Wang; Xiaobing Dou; Ximei Zhang; Songtao Li; Lyndsey Vu; Tong Yao; Zhenyuan Song
Journal:  Metabolism       Date:  2013-03-12       Impact factor: 8.694

10.  Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.

Authors:  L Sieminska; D Niedziolka; A Pillich; B Kos-Kudla; B Marek; M Nowak; H Borgiel-Marek
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.